GoAI
Get started
SSY Group Limited logo

SSY Group Limited

2005.HK

HKSEHealthcareMedical - Pharmaceuticals

Open in GoAI

Latest quote

HK$2.485

+HK$0.02 · +0.81%

Aug 25, 10:30 AM HKT

2005.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was founded in 1999 and is headquartered in Wan Chai, Hong Kong.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
Headquarters
HK
CEO
Ji Guang Qu
Listed since
Dec 20, 2005
Employees
5,472

Market position

Day range

Current HK$2.485

52-week range

Current HK$2.485

Open
HK$2.465
Previous close
HK$2.465
Volume
1.99M
0.42× average
Average volume
4.79M
Average daily volume
Market cap
7.19B HKD
Beta
0.52
Market reference 1
50-day average
HK$2.348
+5.83% above average
200-day average
HK$2.6161
-5.01% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
10.54B HKD
P/E (TTM)
15.5×
P/B (TTM)
0.99×
P/S (TTM)
1.72×
EV / EBITDA
10.18×
Earnings yield
5.67%
Free cash flow yield
3.61%
Dividend yield
3.22%

Profitability & efficiency

Gross margin
41.56%
Operating margin
15.10%
Net margin
11.30%
Return on equity
6.45%
Return on assets
3.67%
Return on invested capital
4.51%

Financial health

Debt / equity
0.55×
Current ratio
1.89×
Altman Z-score
3.06
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends61%43%25%7%Gross margin, FY2021: 56.71%Gross margin, FY2022: 53.46%Gross margin, FY2023: 56.01%Gross margin, FY2024: 50.37%Gross margin, FY2025: 41.56%Operating margin, FY2021: 18.45%Operating margin, FY2022: 22.13%Operating margin, FY2023: 25.36%Operating margin, FY2024: 23.27%Operating margin, FY2025: 15.10%Net margin, FY2021: 14.66%Net margin, FY2022: 17.45%Net margin, FY2023: 20.40%Net margin, FY2024: 18.38%Net margin, FY2025: 11.30%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 56.71%. Gross margin FY2022 53.46%. Gross margin FY2023 56.01%. Gross margin FY2024 50.37%. Gross margin FY2025 41.56%. Operating margin FY2021 18.45%. Operating margin FY2022 22.13%. Operating margin FY2023 25.36%. Operating margin FY2024 23.27%. Operating margin FY2025 15.10%. Net margin FY2021 14.66%. Net margin FY2022 17.45%. Net margin FY2023 20.40%. Net margin FY2024 18.38%. Net margin FY2025 11.30%.

Income trends

Revenue

4.17B HKD-27.85%

Operating income

628.91M HKD-53.19%

Net income

470.64M HKD-55.65%
Income trends across reported periods7.06B HKD4.67B HKD2.27B HKD−128.6M HKDRevenue, FY2021: 5.36B HKDRevenue, FY2022: 6.43B HKDRevenue, FY2023: 6.46B HKDRevenue, FY2024: 5.77B HKDRevenue, FY2025: 4.17B HKDOperating income, FY2021: 988.09M HKDOperating income, FY2022: 1.42B HKDOperating income, FY2023: 1.64B HKDOperating income, FY2024: 1.34B HKDOperating income, FY2025: 628.91M HKDNet income, FY2021: 785.53M HKDNet income, FY2022: 1.12B HKDNet income, FY2023: 1.32B HKDNet income, FY2024: 1.06B HKDNet income, FY2025: 470.64M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 5.36B HKD. Revenue FY2022 6.43B HKD. Revenue FY2023 6.46B HKD. Revenue FY2024 5.77B HKD. Revenue FY2025 4.17B HKD. Operating income FY2021 988.09M HKD. Operating income FY2022 1.42B HKD. Operating income FY2023 1.64B HKD. Operating income FY2024 1.34B HKD. Operating income FY2025 628.91M HKD. Net income FY2021 785.53M HKD. Net income FY2022 1.12B HKD. Net income FY2023 1.32B HKD. Net income FY2024 1.06B HKD. Net income FY2025 470.64M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue4.17B HKD5.77B HKD6.46B HKD6.43B HKD5.36B HKD
Cost of goods sold2.43B HKD2.86B HKD2.84B HKD2.99B HKD2.32B HKD
Gross profit1.73B HKD2.91B HKD3.62B HKD3.44B HKD3.04B HKD
Research and development244.03M HKD265.97M HKD289.75M HKD259.1M HKD247.99M HKD
Selling, general, and administrative1.07B HKD1.45B HKD1.53B HKD1.95B HKD2.02B HKD
Operating expenses1.1B HKD1.56B HKD1.98B HKD2.14B HKD2.18B HKD
Interest income21.12M HKD29.55M HKD33.92M HKD29.2M HKD24.71M HKD
Interest expense105.63M HKD126.88M HKD125.41M HKD88.25M HKD61.3M HKD
Depreciation and amortization439.84M HKD394.9M HKD405.57M HKD371.06M HKD389.81M HKD
Operating income628.91M HKD1.34B HKD1.64B HKD1.42B HKD988.09M HKD
Net income470.64M HKD1.06B HKD1.32B HKD1.12B HKD785.53M HKD

Company facts updated Aug 25, 2026.

Earnings

Latest EPS result
0.06

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.270.20.130.05Q2 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25Q3 '25Q1 '26
Q2 2022, reported Jun 30, 2022: actual 0.191, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 28, 2023: actual 0.186, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 29, 2023: actual 0.214, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 27, 2024: actual 0.229, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 28, 2024: actual 0.231, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 28, 2025: actual 0.127, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 28, 2025: actual 0.096, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 27, 2026: actual 0.064, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates8.6B6.29B3.98B1.68BQ1 '23MissQ3 '23No estimateQ1 '24MissQ3 '24No estimateQ1 '25No estimateQ3 '25No estimateQ1 '26MetQ3 '26Estimate
Q1 2023, reported Mar 28, 2023: actual 3.03B HKD, estimate 8.11B HKD, surprise -62.63%, Miss. Q3 2023, reported Aug 29, 2023: actual 3.33B HKD, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 27, 2024: actual 3.13B HKD, estimate 7.58B HKD, surprise -58.73%, Miss. Q3 2024, reported Aug 28, 2024: actual 3.34B HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 28, 2025: actual 2.43B HKD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 28, 2025: actual 2.15B HKD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 27, 2026: actual 2.02B HKD, estimate 2.02B HKD, surprise 0.00%, Met estimate. Q3 2026, reported Aug 26, 2026: actual —, estimate 1.97B HKD, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.145

2025 complete year+45.0% since 2021

2026 partial: HK$0.03

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend May 20, 2026

HK$0.03

Semi-Annual

Record May 21, 2026 · Payment Jun 4, 2026

Dividend

Ex-dividend Sep 11, 2025

HK$0.05

Semi-Annual

Record Sep 12, 2025 · Payment Sep 26, 2025

Dividend

Ex-dividend May 20, 2025

HK$0.095

Semi-Annual

Record May 21, 2025 · Payment Jun 3, 2025

Dividend

Ex-dividend Sep 12, 2024

HK$0.08

Semi-Annual

Record Sep 13, 2024 · Payment Sep 27, 2024

Dividend

Ex-dividend May 21, 2024

HK$0.10

Semi-Annual

Record May 22, 2024 · Payment Jun 4, 2024

Dividend

Ex-dividend Sep 14, 2023

HK$0.07

Semi-Annual

Record Sep 18, 2023 · Payment Sep 27, 2023

2005.HK peers

WuXi AppTec Co., Ltd. logo

2359.HK

WuXi AppTec Co., Ltd.

HK$185

-6.42%

Jiangsu Hengrui Pharmaceuticals Co.,Ltd logo

1276.HK

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

HK$46.04

-0.90%

BeOne Medicines AG logo

6160.HK

BeOne Medicines AG

HK$211

-4.70%

WuXi Biologics (Cayman) Inc. logo

2269.HK

WuXi Biologics (Cayman) Inc.

HK$49.50

+1.85%

Hansoh Pharmaceutical Group Company Limited logo

3692.HK

Hansoh Pharmaceutical Group Company Limited

HK$31.06

-6.11%

Innovent Biologics, Inc. logo

1801.HK

Innovent Biologics, Inc.

HK$96.50

-3.02%

ETFs holding 2005.HK

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core MSCI Emerging Markets ETF logoiShares Core MSCI Emerging Markets ETFIEMG
Market value
5.16M
Weight
0.00%
AUM
158.05B USD
Expense ratio
0.09%
Price / 1D
$80.49-1.32%
Vanguard Total International Stock ETF logoVanguard Total International Stock ETFVXUS
Market value
5M
Weight
0.00%
AUM
646.2B USD
Expense ratio
0.05%
Price / 1D
$87.20-0.58%
Vanguard FTSE Emerging Markets ETF logoVanguard FTSE Emerging Markets ETFVWO
Market value
4.84M
Weight
0.00%
AUM
162.3B USD
Expense ratio
0.06%
Price / 1D
$59.97-0.79%
Avantis Emerging Markets Equity ETF logoAvantis Emerging Markets Equity ETFAVEM
Market value
2.85M
Weight
0.01%
AUM
27.89B USD
Expense ratio
0.33%
Price / 1D
$93.11-1.20%
Vanguard FTSE All-World ex-US Small-Cap ETF logoVanguard FTSE All-World ex-US Small-Cap ETFVSS
Market value
1.1M
Weight
0.01%
AUM
13.6B USD
Expense ratio
0.06%
Price / 1D
$158.95-0.69%
iShares Core MSCI Total International Stock ETF logoiShares Core MSCI Total International Stock ETFIXUS
Market value
765.2K
Weight
0.00%
AUM
60.91B USD
Expense ratio
0.07%
Price / 1D
$97.40-0.56%
Dimensional World ex U.S. Core Equity 2 ETF logoDimensional World ex U.S. Core Equity 2 ETFDFAX
Market value
388.61K
Weight
0.00%
AUM
12.57B USD
Expense ratio
0.28%
Price / 1D
$37.96-0.52%
Avantis Emerging Markets Value ETF logoAvantis Emerging Markets Value ETFAVES
Market value
350.16K
Weight
0.02%
AUM
1.5B USD
Expense ratio
0.36%
Price / 1D
$65.04-0.18%

Continue in GoAI

Research 2005.HK

research.disclaimer